Juhan-Vague I, Moerman B, De Cock F, Aillaud M F, Collen D
Thromb Res. 1984 Mar 1;33(5):523-30. doi: 10.1016/0049-3848(84)90018-5.
Rapid inhibition of tissue-type plasminogen activator (t-PA) in human plasma was measured by addition of 5 IU (50 ng) of purified t-PA per ml plasma and measurement of residual t-PA in the euglobulin precipitate after 5 min incubation at 37 degrees C. The recovery of both t-PA activity and t-PA related antigen in pooled plasma from healthy individuals was approximately 90 percent, indicating that one ml of pooled normal plasma inhibits less than 1 IU or 10 ng of t-PA within 5 min. Of 20 control subjects 13 had less than 1 IU inhibitor activity; 5 subjects inhibited between 1 and 3 IU of t-PA and 2 subjects inhibited around 4.5 IU. The inhibitor titer in the latter two had however decreased to 1.8 and 2.7 IU after two days. Markedly increased rapid inhibition of t-PA (greater than 4 IU per ml) was found in plasma of patients with severe liver disease (3 of 8), pancreatitis (4 of 8), malignancy (5 of 26), but only very occasionally and transiently in that of patients with myocardial infarction (5 of 28) or deep vein thrombosis (2 of 9). Increased inhibition was observed on the first day following coronary bypass (22 of 42) or open heart (16 of 27) surgery but this had disappeared in 15 of 16 patients on the fifth postoperative day. Titration of inhibitor levels revealed maximal amounts of 30 to 50 IU per ml plasma.(ABSTRACT TRUNCATED AT 250 WORDS)
通过在每毫升血浆中加入5国际单位(50纳克)纯化的组织型纤溶酶原激活剂(t-PA),并在37℃孵育5分钟后测量优球蛋白沉淀中的残余t-PA,来测定人血浆中t-PA的快速抑制情况。健康个体混合血浆中t-PA活性和t-PA相关抗原的回收率约为90%,这表明1毫升混合正常血浆在5分钟内抑制的t-PA少于1国际单位或10纳克。20名对照受试者中,13人的抑制剂活性低于1国际单位;5名受试者抑制1至3国际单位的t-PA,2名受试者抑制约4.5国际单位。然而,后两名受试者的抑制剂效价在两天后降至1.8和2.7国际单位。在重症肝病患者(8例中的3例)、胰腺炎患者(8例中的4例)、恶性肿瘤患者(26例中的5例)的血浆中发现t-PA的快速抑制明显增加(每毫升大于4国际单位),但在心肌梗死患者(28例中的5例)或深静脉血栓形成患者(9例中的2例)中仅偶尔且短暂出现。在冠状动脉搭桥手术(42例中的22例)或心脏直视手术(27例中的16例)后的第一天观察到抑制增加,但在术后第五天,16例患者中有15例这种情况消失。抑制剂水平滴定显示,每毫升血浆中最大量为30至50国际单位。(摘要截断于250字)